Test Price
2,500 AED✅ Home Collection Available
Procainamide and N-Acetylprocainamide (NAPA) Test in UAE | Clinical Chemistry | 2500 AED
Executive Summary & Core Metrics
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Procainamide and NAPA test quantifies the antiarrhythmic drug procainamide and its active metabolite N‑acetylprocainamide (NAPA) in serum to guide safe, effective ventricular arrhythmia management. The test utilizes a validated immunoassay technique compliant with DHA and MOHAP standards, ensuring precise dual quantification for optimized therapeutic dosing.
| Aspect | Our Test (ISO 9001:2015) | Closest Alternative |
|---|---|---|
| Precision | 99.9% Sensitivity, dual quantification (Procainamide + NAPA) | Immunoassay only; variable NAPA reporting |
| Methodology | Validated Immunoassay (DHA/MOHAP compliant) | Non‑standardized immunoassay |
| Speed & Logistics | VIP Home Collection (8 AM–11 PM), cold‑chain transport, report in 2–3 weeks | In‑clinic draw; longer TAT |
Physician Insight & Safety Protocols
“As a General Practitioner overseeing therapeutic drug monitoring, I emphasize that procainamide and NAPA levels must be interpreted alongside ECG findings and clinical status. This test, when performed precisely and on time, prevents life‑threatening arrhythmias and drug‑induced lupus. Always correlate results with the patient’s symptoms and renal function.”
— Dr. Ajay Singh, DHA Registration ID: 36234132
Medication Safety Advisory
Important Precautions
Do not discontinue prescribed medication without consulting your doctor. Abrupt cessation can trigger severe arrhythmia recurrence. Always consult a healthcare professional before making any changes to your medication regimen.
Safety Exclusion Criteria & ER Red Flags
- Known hypersensitivity to procainamide or NAPA.
- Complete heart block or severe conduction defects without pacemaker.
- Myasthenia gravis (relative contraindication).
- Severe lupus erythematosus (drug‑induced exacerbation risk).
- Seek Emergency Care if: New‑onset chest pain, fainting, extreme dizziness, or signs of lupus‑like syndrome (joint pain, facial rash, fever).
Patient FAQ & Clinical Guidance
1. What is a procainamide and NAPA test?
A Procainamide and NAPA test measures blood levels of the antiarrhythmic drug and its active metabolite to prevent toxicity. This monitoring is essential for tailoring dosing in patients with ventricular tachycardia, especially when renal function changes. The test requires a serum sample drawn just before the next scheduled dose at steady state.
2. How should I prepare for the procainamide blood draw?
Collect the blood sample just before your next dose is due, while you are at steady state. A minimum of 1 mL serum from a plain red‑top tube (no gel barrier) is required; the sample must be kept refrigerated and never frozen. Our phlebotomist will guide you through the exact timing and handle cold‑chain transport.
3. Why does the test take 2–3 weeks for results?
The sample is sent to a specialized reference laboratory that performs batch‑mode immunoassay validation to ensure 99.9% diagnostic accuracy. This ISO‑certified process, combined with strict cold‑chain logistics, guarantees clinically reliable results but requires a scheduled processing window.
UAE Regulatory & Data Privacy Adherence
Compliance Framework
DNA Labs UAE strictly complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. All operations are conducted under DHA Facility License Number 1143.
Clinical & Logistical Metadata
| Test Name | Procainamide and N-Acetylprocainamide (NAPA) Test |
| Price (AED) | 2500 |
| Turnaround Time | 2–3 Weeks |
| Sample Type / Matrix | Serum (Standard Peripheral Blood Draw) |
| Methodology Used | Validated Immunoassay (DHA/MOHAP Compliant) |
| ICD-10-CM Code | Z51.81 |
| LOINC Code | 3528-7 |
| DHA Facility License & Laboratory Address | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DHA License 1143 |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians